As of 2025-01-15, the Relative Valuation of Infinity Pharmaceuticals Inc (INFI) is (32.90) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.04 USD, the upside of Infinity Pharmaceuticals Inc based on Relative Valuation is -73695.9%.
The range of the Relative Valuation is (33.86) - (37.89) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 26.9x - 43.0x | 33.9x |
| Forward P/E multiples | 18.3x - 30.1x | 18.3x |
| Fair Price | (33.86) - (37.89) | (32.90) |
| Upside | -75838.9% - -84862.1% | -73695.9% |
| Date | P/E |